Literature DB >> 9506350

Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience.

M Uematsu1, A Shioda, K Tahara, T Fukui, F Yamamoto, G Tsumatori, Y Ozeki, T Aoki, M Watanabe, S Kusano.   

Abstract

BACKGROUND: Stereotactic radiation therapy is highly effective in the treatment of small brain metastases, regardless of the histology. This suggests that small extracranial malignancies may be curable with similar radiation therapy. The authors developed a novel treatment unit for administering such therapy.
METHODS: The unit consisted of a linear accelerator (linac), an X-ray simulator (X-S), computed tomography (CT), and a table. The gantry axes of the three machines were coaxial and could be matched by rotating the table. Patients were instructed to perform shallow respiration with oxygen. The motion of the tumor was monitored with the X-S. When the motion was slight enough, the table was rotated to the CT. To include all geometric movement on the CT images, each scan was made while the patient was performing shallow respiration. After the CT positioning, the table was rotated to the linac, and non-coplanar treatment was given. Beginning in October 1994, 45 patients with 23 primary or 43 metastatic lung carcinomas were treated. Radiation doses at the 80% isodose line were 30-75 gray in 5-15 fractions over 1-3 weeks with or without conventional radiation therapy.
RESULTS: The treatment was performed with no or minimal adverse acute symptoms. The daily treatment time was short. During a median follow-up of 11 months, local progression occurred in 2 of 66 lesions. Interstitial changes in the lung were limited.
CONCLUSIONS: With this unit and procedure, focal radiation therapy similar to stereotactic radiation therapy is possible for extracranial sites. The preliminary experience appeared safe and promising, and further exploration of this approach is warranted.

Entities:  

Mesh:

Year:  1998        PMID: 9506350     DOI: 10.1002/(sici)1097-0142(19980315)82:6<1062::aid-cncr8>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  41 in total

1.  A pooled analysis of stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small cell lung cancer: is failure to recruit patients into randomized trials also an answer to the research question?

Authors:  Carsten Nieder; Nicolaus H Andratschke; Matthias Guckenberger
Journal:  Ann Transl Med       Date:  2015-07

Review 2.  Organ motion in image-guided radiotherapy: lessons from real-time tumor-tracking radiotherapy.

Authors:  Hiroki Shirato; Shinichi Shimizu; Kei Kitamura; Rikiya Onimaru
Journal:  Int J Clin Oncol       Date:  2007-02-25       Impact factor: 3.402

3.  A method for improved verification of entire IMRT plans by film dosimetry.

Authors:  Vesna Jacob; Peter Kneschaurek
Journal:  Strahlenther Onkol       Date:  2009-02-18       Impact factor: 3.621

Review 4.  Are three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy?

Authors:  Anna O Simeonova; Katharina Fleckenstein; Hansjörg Wertz; Anian Frauenfeld; Judit Boda-Heggemann; Frank Lohr; Frederik Wenz
Journal:  Transl Lung Cancer Res       Date:  2012-03

Review 5.  The role of stereotactic radiotherapy in the treatment of oligometastases.

Authors:  Gregory M M Videtic
Journal:  Curr Oncol Rep       Date:  2014-07       Impact factor: 5.075

Review 6.  Evidence for surgical resections in oligometastatic lung cancer.

Authors:  Rafael A S Fernandez; Rainbow W H Lau; Jacky Y K Ho; Peter S Y Yu; Simon C Y Chow; Innes Y P Wan; Calvin S H Ng
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

7.  Tracing the earliest medical uses of high dose-per-fraction external beam radiation.

Authors:  Brian D Kavanagh
Journal:  J Radiosurg SBRT       Date:  2011

8.  Hypofractionated radiotherapy for lung tumors with online cone beam CT guidance and active breathing control.

Authors:  Yali Shen; Hong Zhang; Jin Wang; Renming Zhong; Xiaoqing Jiang; Qinfeng Xu; Xin Wang; Sen Bai; Feng Xu
Journal:  Radiat Oncol       Date:  2010-02-27       Impact factor: 3.481

9.  Complications associated with the percutaneous insertion of fiducial markers in the thorax.

Authors:  Nikhil Bhagat; Nicholas Fidelman; Jeremy C Durack; Jeremy Collins; Roy L Gordon; Jeanne M LaBerge; Robert K Kerlan
Journal:  Cardiovasc Intervent Radiol       Date:  2010-07-27       Impact factor: 2.740

Review 10.  Oligometastases and oligo-recurrence: the new era of cancer therapy.

Authors:  Yuzuru Niibe; Kazushige Hayakawa
Journal:  Jpn J Clin Oncol       Date:  2010-01-04       Impact factor: 3.019

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.